| Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. |
Rawal RK, Tripathi R, Katti SB, Pannecouque C, De Clercq E |
2008 |
| Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. |
Chen X, Zhan P, Pannecouque C, Balzarini J, De Clercq E, Liu X |
2012 |
| Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. |
Balzarini J, Orzeszko B, Maurin JK, Orzeszko A |
2007 |
| Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors. |
Gu SX, Li ZM, Ma XD, Yang SQ, He QQ, Chen FE, De Clercq E, Balzarini J, Pannecouque C |
2012 |
| Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. |
Deng BL, Zhao Y, Hartman TL, Watson KM, Buckheit RW, Pannecouque C, De Clercq E, Cushman M |
2009 |
| Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors. |
Wang YP, Chen FE, De Clercq E, Balzarini J, Pannecouque C |
2009 |
| Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity. |
Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C |
2008 |
| Synthesis and anti-HIV activity evaluation of 1-[(alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. |
Ji L, Chen FE, Xie B, De Clercq E, Balzarini J, Pannecouque C |
2007 |
| Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. |
Zhan P, Liu X, Fang Z, Li Z, Pannecouque C, De Clercq E |
2009 |
| Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors. |
Ribone SR, Leen V, Madrid M, Dehaen W, Daelemans D, Pannecouque C, Briñón MC |
2012 |
| Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. |
Yang S, Pannecouque C, Daelemans D, Ma XD, Liu Y, Chen FE, De Clercq E |
2013 |